Awards & Advancement

Minerva Neurosciences expands executive team

Thursday, March 6, 2014 10:30 AM

Minerva Neurosciences, a developer of new therapies to treat neuropsychiatric diseases and disorders, has launched the new company web site (www.minervaneurosciences.com) following the successful transfer of the Minerva Neurosciences corporate headquarters from New Jersey to Cambridge, Mass. The establishment of a new corporate headquarters follows the recent appointment of Rogerio Vivaldi, M.D., MBA, as the new president and CEO, and Marc Beer as the new chairman of the board of directors of Minerva Neurosciences. The company was founded in 2013 by the merger of Cyrenaic Pharmaceuticals and Sonkei Pharmaceuticals.

More... »

WIRB Copernicus Group

Steven W. J. Kent joins CRF Health’s board of directors

Monday, March 3, 2014 09:00 AM

CRF Health, a provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials, has announced that Steven W. J. Kent, former CEO of ClinPhone and former president of Perceptive Informatics, has joined the company’s board of directors as chairman.

More... »


CluePoints expands global team

Friday, February 28, 2014 11:36 AM

CluePoints, a provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has announced three new appointments to its global team. John Colby and Elizabeth Polvent join the company's U.S business development team, fulfilling a key element in its strategy for growth, while CluePoints also welcomes Jean Stéphenne, president of the board of directors of GlaxoSmithKline Biologicals, as a member of its board.

More... »

Ariad appoints Alexander J. Denner to board of directors

Monday, February 24, 2014 12:26 PM

Ariad Pharmaceuticals, an integrated global oncology company, has appointed Alexander J. Denner, Ph.D., to a two-year term on the company's board of directors, effective immediately. With the addition of Denner, who is the chief investment officer and founding partner of Sarissa Capital Management LP, the board now comprises nine directors, eight of whom are independent. The company also will appoint another independent director to the board, who will be selected by the board and be subject to Denner's concurrence.

More... »

UCB announces CEO succession plan

Monday, February 24, 2014 12:09 PM

UCB, a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions for the immune system and of the central nervous system, and CEO Roch Doliveux have announced the implementation of its CEO succession plan.

More... »

Inovio Pharmaceuticals expands senior management team

Friday, February 21, 2014 02:38 PM

Inovio Pharmaceuticals has expanded its senior management team with two appointments to help advance the company's growing pipeline of preclinical and clinical DNA vaccines. Inovio has appointed Dr. Laurent Humeau as vice president of R&D and Dr. Jan Marie-Albert Van Tornout as vice president of Clinical Development.

More... »

ERT named preferred provider for key quality of life assessments

Friday, February 21, 2014 02:33 PM

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has been named a preferred provider for the administration of the EuroQol Group’s EQ-5D patient reported outcome (PRO) assessment. Specifically, VIAPhone, ERT’s Interactive Voice Response (IVR) system, has been approved to capture both the EQ-5D-3L and the EQ-5D-5L versions of the quality of life assessment. 

More... »

Laurence Burke joins Exco InTouch as vice president of operations

Friday, February 21, 2014 02:12 PM

Exco InTouch, a provider of patient engagement and data capture solutions for clinical research and healthcare providers, has appointed Laurence Burke vice president of operations. Chief amongst his responsibilities is ensuring that processes are as streamlined and efficient as possible for customers, whilst also ensuring full continuity of robust delivery programs as Exco InTouch continues to grow the volume of its business. Burke will have responsibility for operations in servicing customers in the clinical, late phase and mHealth fields.

More... »

Spark Therapeutics appoints Elliott Sigal to board of directors

Friday, February 14, 2014 01:27 PM

Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, has appointed Elliott Sigal, M.D., Ph.D., former director, executive vice president and chief scientific officer of Bristol-Myers Squibb, to its board of directors. Elliott led Bristol-Myers Squibb during its ascent as a biopharmaceutical leader and built one of the industry's most productive R&D organizations through his forward-thinking approach to innovation.

More... »

James Brown elected to Safe-Biopharma board of directors

Friday, February 14, 2014 01:18 PM

SAFE-BioPharma Association, the nonprofit collaboration that developed and manages the global SAFE-BioPharma digital identity and digital signature standard, has elected James W. Brown, Ph.D., chief operating officer, Regenx Biosciences to its board of directors.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs